A Phase II study of SU5416 in patients with advanced or recurrent head and neck cancers Academic Article uri icon

Overview

MeSH Major

  • Angiogenesis Inhibitors
  • Head and Neck Neoplasms
  • Indoles
  • Neoplasms, Squamous Cell
  • Pyrroles

abstract

  • Treatment with SU5416 in patients with head and neck cancers is feasible, but objective responses are rare. Studies evaluating more potent anti-angiogenic agents in this disease are of interest.

publication date

  • April 2007

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1007/s10637-006-9011-x

PubMed ID

  • 16983506

Additional Document Info

start page

  • 165

end page

  • 72

volume

  • 25

number

  • 2